Key result
Treatment with escitalopram for 8 weeks significantly decreased heart rate compared to placebo (66.8 vs 74.1 bpm) in patients with hypertension and depression.
Why the study?
Does escitalopram reduce blood pressure and heart rate in individuals with hypertension and depression?
RCT (n=30)
Double-blind
Block randomized
No
Does escitalopram reduce blood pressure and heart rate in individuals with hypertension and depression?
Absolute Event Rate: 66.8% vs 74.1%
p-value: p=0.046
May lower heart rate in hypertension with depression; leaves open blood pressure effects and outcome impact.
Objective: To observe the influence of the treatment of depression on the regularization of blood pressure and heart rate of individuals with hypertension and depression. Methods: A total of 30 individuals who were being treated for hypertension were diagnosed for depression participated in this study. Escitalopram (10 - 20 mg) was administered to 15 individuals, while the other 15 received placebo. These individuals were followed for 8 weeks with regular monitoring of blood pressure and heart rate. Scores on the Hamilton Depression Rating Scale were evaluated within the first, second, fourth, and eighth weeks of the study onset. The same 30 individuals were further divided into groups who had or had not undergone depression remission, regardless of whether the individual was receiving the active drug or placebo. Likewise, in order to observe the influence of sleep regularization, the patients were divided into groups based on whether their sleep quality had improved. Results: There was a significant decrease in the average systolic blood pressure of the normal-sleep group (-20.07 ± 13.45 vs. -9.43 ± 14.87 mmHg, p = 0.04). Heart rate was lower in the escitalopram than in the placebo group: 66.88 ± 9.62 vs. 74.19 ± 9.55 bpm, p = 0.04. Conclusion: Treatment with escitalopram decreased heart rate, improved sleep quality, and decreased blood pressure.
No takes yet. Share an insight, caveat, or question.
Peixoto et al. (2015) conducted an RCT in Hypertension and Depression (n=30). Escitalopram vs. Placebo was evaluated on Heart rate at 8 weeks (p=0.046). Treatment with escitalopram for 8 weeks significantly decreased heart rate compared to placebo (66.8 vs 74.1 bpm) in patients with hypertension and depression.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: